Fintel reports that on May 29, 2026, Cantor Fitzgerald initiated coverage of Sensei Biotherapeutics (NasdaqCM:SNSE) with a Overweight recommendation. Analyst Price Forecast Suggests 189.94% Upside As ...

Sensei Biotherapeutics Inc. (NASDAQ:SNSE) is one of the best performing NASDAQ stocks according to Wall Street analysts. On March 30, Sensei Biotherapeutics shifted its focus following the acquisition ...

Today, Sensei announced the launch of Sensei Cloud Apps, a new cloud-based platform designed to help dental practices start each day prepared, stay connected to patients, and operate more efficiently ...

Leading luxury wellness brand Sensei — known for some of the world’s most unique and exclusive wellness destinations, programs, and retreats —has launched Collections, a new curated suite of services ...

Sensei Biotherapeutics is laying off 46% of its workforce as the cancer-focused biotech looks to preserve cash to take its immune checkpoint inhibitor through phase 2. The asset in question, dubbed ...

Sensei Biotherapeutics is abandoning its sole clinical-stage drug and warning of imminent layoffs as the company mulls its options. Two weeks ago, the biotech reported phase 1/2 data for its ...

Toronto, April 29, 2024 (GLOBE NEWSWIRE) -- TORONTO, CANADA, April 23, 2024 (Globenewswire) -- Sensei Labs announces the launch of AI in its award-winning Enterprise Orchestration platform, Conductor.

In today’s challenging economic climate, small businesses are constantly battling financial obstacles. Lead Sensei, under the leadership of CEO Daniel Bradley, is stepping in as a ...